The efficacy and mechanism of combined treatment of Reduning,budesonide and erythromycin sequential therapy in the treatment of children with mycoplasma pneumonia
10.3760/cma.j.issn.1008-6706.2012.23.012
- VernacularTitle:热毒宁、布地奈德、红霉素序贯疗法治疗小儿支原体肺炎的疗效及其作用机制
- Author:
Bi KANG
- Publication Type:Journal Article
- Keywords:
Mycoplasma pneumonia;
Reduning injection;
Budesonide;
Erythromycin;
Children
- From:
Chinese Journal of Primary Medicine and Pharmacy
2012;(23):3543-3545
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the efficacy of the combined treatment of Reduning,budesonide and erythromycin sequential therapy in the treatment of children with mycoplasma pneumonia and investigate its mechanism.Methods 78 children with mycoplasma pneumonia were randomly divided into two groups,each group 39 cases.The control group were given budesonide and erythromycin sequential therapy,and the observation group were given Reduning injection on the basis of the control group.Both groups were treated for 2 weeks.The clinical efficacy was observed,and before and after treatment,the pulmonary function was tested in the both groups.Results The total effective rate of the observation group was 94.87％,which was higher than that of the control group(86.62％)(x2=6.683,P＜0.05);The fever,cough improved,pulmonary rales disappeared,wheeze disappeared and hospital stay time of the observation group were significantly shorter than the control group(all P＜0.01);The FVC,FEV1 and PEF of the observation group were higher than those of the control group(all P＜0.05).Conclusion On the basis of the combined treatment of budesonide and erythromycin,the addition of Reduning injection can improve clinical effect and shorten the symptoms and signs improve time,improve lung function,chich may in association with regulating humoral immunity and reducing the levels of inflammatory cytokines.
